Australia markets open in 8 hours 13 minutes

Aroa Biosurgery Limited (ARX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.5500-0.0050 (-0.90%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 189.31M
Enterprise value 168.41M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.98
Price/book (mrq)2.17
Enterprise value/revenue 2.66
Enterprise value/EBITDA 116.20

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-39.89%
S&P500 52-week change 324.78%
52-week high 30.9950
52-week low 30.4750
50-day moving average 30.5271
200-day moving average 30.6688

Share statistics

Avg vol (3-month) 3315.99k
Avg vol (10-day) 3676.05k
Shares outstanding 5344.21M
Implied shares outstanding 6347.34M
Float 8243.48M
% held by insiders 127.13%
% held by institutions 119.32%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in NZD.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -15.39%
Operating margin (ttm)-13.37%

Management effectiveness

Return on assets (ttm)-5.86%
Return on equity (ttm)-10.80%

Income statement

Revenue (ttm)69.07M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)9.30%
Gross profit (ttm)N/A
EBITDA -7.3M
Net income avi to common (ttm)-10.63M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.23M
Total cash per share (mrq)0.09
Total debt (mrq)7.43M
Total debt/equity (mrq)7.83%
Current ratio (mrq)7.26
Book value per share (mrq)0.28

Cash flow statement

Operating cash flow (ttm)-7.38M
Levered free cash flow (ttm)-15.81M